Panavance Therapeutics Inc.
0 followers
‌
Panavance Therapeutics Inc. is a US, clinical-stage pharmaceutical company established in 2021 by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. Panavance is focused on advancing the development of GP-2250, a novel oncology therapeutic intended to... Read more
Industries
+1
Headquarters
Employees
Links
Org chart
Greg Bosch
Chairman & CEO
Greg Bosch
Collapse
Ben Steinmetz
Chief Commercial Officer
José Iglesias
Chief Medical Officer
Tom Hess
Chief Financial Officer
Thomas P. Hess
Chief Financial Officer
